{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "regularMarketChangePercent": -1.3054831, "regularMarketPrice": 37.8, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.68, "epsCurrentYear": -1.88, "priceEpsCurrentYear": -20.106382, "sharesOutstanding": 205315008, "bookValue": 15.127, "fiftyDayAverage": 39.079, "fiftyDayAverageChange": -1.2789993, "fiftyDayAverageChangePercent": -0.03272856, "twoHundredDayAverage": 38.9915, "twoHundredDayAverageChange": -1.1915016, "twoHundredDayAverageChangePercent": -0.030557983, "marketCap": 7760907264, "priceToBook": 2.4988432, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1340154000000, "priceHint": 2, "marketState": "POSTPOST", "exchange": "TWO", "shortName": "MYCENAX BIOTECH INC.", "longName": "Mycenax Biotech Inc.", "messageBoardId": "finmb_49941235", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChange": -0.5, "regularMarketTime": 1684128605, "regularMarketDayHigh": 38.4, "regularMarketDayRange": "37.6 - 38.4", "regularMarketDayLow": 37.6, "regularMarketVolume": 373103, "regularMarketPreviousClose": 38.3, "bid": 37.8, "ask": 37.85, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 38.1, "averageDailyVolume3Month": 638392, "averageDailyVolume10Day": 585900, "fiftyTwoWeekLowChange": 4.8999977, "fiftyTwoWeekLowChangePercent": 0.1489361, "fiftyTwoWeekRange": "32.9 - 55.0", "fiftyTwoWeekHighChange": -17.2, "fiftyTwoWeekHighChangePercent": -0.31272727, "fiftyTwoWeekLow": 32.9, "fiftyTwoWeekHigh": 55.0, "symbol": "4726.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 66, Shengyi 2nd Road", "address2": "7th Floor", "city": "Zhubei", "zip": "302041", "country": "Taiwan", "phone": "886 37 586 988", "fax": "886 37 586 188", "website": "https://www.mycenax.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well as plasmids and DNA vaccines. It also provides process development solutions, including development of production cell lines, upstream and downstream process development, process scale-up, formulation development, and analytical methods; in-house analytical services; GMP manufacturing services, such as drug substance and products manufacturing, and cell banking; and manufacturing technologies. The company was founded in 2001 and is headquartered in Zhubei, Taiwan.", "fullTimeEmployees": 387, "companyOfficers": [{"maxAge": 1, "name": "Michael  Hwang", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jiong Xiang  Chen", "title": "Mang. of Fin. and Accounting Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}